Two Thai Covid-19 vaccines getting to human trial stage


A Covid-19 vaccine candidate on a shelf during testing at the Chula Vaccine Research Center, run by Chulalongkorn University in Bangkok, Thailand. - AP

BANGKOK (Xinhua): Thailand's National Vaccine Institute on Monday (Nov 23) announced that two of seven Covid-19 vaccine candidates have been successfully tested on animals and are moving onto human trials.

The two candidates entering Phase 2 trials on humans are the mRNA vaccine being developed by Chula Vaccine Research Centre (Chula VRC) and the DNA vaccine developed by BioNet-Asia, said Dr. Nakorn Premsri, director of the institute.

Chula VRC expects its mRNA vaccine prototype will enter human trials around April 19 next year.

The mRNA prototype will first be tested on 72 volunteers, and if the tests succeed, the Chula prototype will enter second-phase human trials on 600 people.

Meanwhile, the five other vaccine candidates are all currently being tested on animals, according to Nakorn.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 18
Cxense type: free
User access status: 3

Thailand , covid-19 , vaccine , human trials

   

Did you find this article insightful?

Yes
No

80% readers found this article insightful

Next In Aseanplus News

Asian fixed income to continue to perform, Manulife says
Myanmar's Covid-19 positivity rate remains below 5 per cent for one month
Asian shares hit a record high after Yellen calls for big spending
Singapore draws S$17.2bil of investments in 2020, most since 2008, despite Covid-19
China to boost reforms for state-owned enterprises
Taiwan cancels more events as local Covid-19 cases rise
Three things Philippine VP Leni Robredo can learn from Biden's victory: Inquirer columnist
Asia markets mostly up on hope for Biden recovery agenda
S.Korea's Kia reviewing electric car tie-up with multiple firms after Apple report
Thai investment in Vietnam on the rise

Stories You'll Enjoy